Evaluation of real‐world efficacy of mepolizumab on SNOT‐22 outcomes in patients with unified airway disease

Evaluation of real‐world efficacy of mepolizumab on SNOT‐22 outcomes in patients with unified airway disease

Saved in:

Bibliographic Details
Main Authors:	Ruperto González‐Pérez, Paloma Poza‐Guedes, María Gabriela Martín‐Voso, Inmaculada Sánchez‐Machín
Format:	Article
Language:	English
Published:	Wiley 2024-11-01
Series:	Clinical and Translational Allergy
Online Access:	https://doi.org/10.1002/clt2.70006
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Real-World Outcomes and Healthcare Utilization of Lanadelumab in Spain: Insights from First Cohort of Difficult-to-Treat Hereditary Angioedema Cases
by: Inmaculada Sánchez-Machín, et al.
Published: (2025-02-01)

Role of Predatory Mites in Persistent Nonoccupational Allergic Rhinitis
by: Paloma Poza Guedes, et al.
Published: (2016-01-01)

A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months
by: Giulia Anna Maria Luigia Costanzo, MD, et al.
Published: (2025-03-01)

Therapeutic Effectiveness of SNOT 22-Based Interdose Interval Adjustment of Dupilumab for Chronic Rhinosinusitis With Nasal Polyps
by: So Yeon Yoon, et al.
Published: (2024-11-01)

SNOT-22 na avaliação dos resultados a curto prazo da septoplastia + turbinoplastia: Estudo prospectivo
by: Nuno Medeiros, et al.
Published: (2021-06-01)

Clinical and Immunological Features in Limpet (<i>Patella</i> sp.) Allergy in Subtropical Areas: A New Trigger for Food Anaphylaxis
by: Elena Mederos-Luis, et al.
Published: (2025-01-01)

A real-world study to evaluate effectiveness of mepolizumab in treating severe asthma in Taiwan (REMIT)
by: Shih-Lung Cheng, et al.
Published: (2025-01-01)

Efficacy of Mepolizumab in the Treatment of Severe Asthma with a Mixed Granulocytic Pattern of Airway Inflammation (Case Report)
by: A. M. Gubareva, et al.
Published: (2024-02-01)

Real-world effectiveness of mepolizumab in Japanese asthma patients with diverse backgrounds: Improvements in rhinosinusitis imaging (J-Real-Mepo)
by: Hiroyuki Nagase, et al.
Published: (2025-07-01)

Elevated mepolizumab levels in patients with severe asthma responsive to 1 year’s mepolizumab treatment
by: Takayasu Nishimaki, MD, et al.
Published: (2025-05-01)

Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis
by: Ravi Ranjan Pradhan, et al.
Published: (2019-01-01)

A Case of Hypereosinophilia With Serositis Responsive to Mepolizumab
by: Emily Jezewski, et al.
Published: (2024-02-01)

Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
by: Manuel David Gil-Sierra, et al.
Published: (2019-11-01)

The effect of mepolizumab dosage form on treatment outcomes in severe asthma
by: Martina Vetchá, et al.
Published: (2025-04-01)

Long Term Effectiveness of Mepolizumab in the Treatment of Chronic Eosinophilic Pneumonia
by: María Longás, et al.
Published: (2025-07-01)

Improving patient outcomes: Mepolizumab’s impact in IL-5-mediated diseases
by: Dipti Gothi, et al.
Published: (2025-05-01)

Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies
by: Mayu Shiomi, et al.
Published: (2025-04-01)

Relapse of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Despite Maintenance Treatment With Low‐Dose Mepolizumab
by: Aurelie Vanthuyne, et al.
Published: (2025-05-01)

Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report
by: Meiying Tao, et al.
Published: (2025-12-01)

The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma
by: Rimkunas A, et al.
Published: (2025-03-01)

Role of Th22 and IL-22 in pathogenesis of allergic airway diseases: Pro-inflammatory or anti-inflammatory effect?
by: Laura Tamasauskiene, et al.
Published: (2018-08-01)

Examining effects of race and chronic rhinosinusitis on asthma; more evidence for unified-airway diseases
by: Donyea L. Moore, et al.
Published: (2025-07-01)

Early Intervention with Mepolizumab, Corticosteroids, and Intravenous Immunoglobulin for Dupilumab-Triggered Eosinophilic Granulomatosis with Polyangiitis: A Case Report
by: Kaburaki S, et al.
Published: (2025-04-01)

Updated insights into adverse events associated with mepolizumab: a disproportionality analysis from the FDA adverse event reporting system database
by: Shan Lin, et al.
Published: (2024-10-01)

Factors affecting upper airway control of NSAID‐exacerbated respiratory disease: A real‐world study of 167 patients
by: Annina Lyly, et al.
Published: (2021-03-01)

World Encephalitis Day 22 Feb, 2023
by: article Editorial
Published: (2023-03-01)

A Unified Virtual Model for Real-Time Visualization and Diagnosis in Architectural Heritage Conservation
by: Federico Luis del Blanco García, et al.
Published: (2024-10-01)

The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic
by: T. V. Beketova, et al.
Published: (2021-03-01)

Positive airway pressure therapy adherence in obstructive sleep apnea patients with or without web-based telemonitoring: A real-world study
by: Xin Ru Qu, et al.
Published: (2025-05-01)

Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma
by: Annina Lyly, et al.
Published: (2025-03-01)

Haemodynamic changes and mean airway pressure threshold in extremely preterm infants (22–24 weeks of gestation) with tension pneumothorax
by: Tomonori Kurimoto, et al.
Published: (2025-05-01)

Childhood experiences and adult prayer or meditation in 22 countries around the world
by: Matt Bradshaw, et al.
Published: (2025-04-01)

Real-world tafamidis experience in hereditary transthyretin amyloidosis with peripheral neuropathy in Brazil
by: Luiz Felipe Pinto, et al.
Published: (2025-01-01)

Psychiatry in the real world
by: Orestis Giotakos
Published: (2025-07-01)

The role of real world data and real world evidence in health technology assessment
by: E. A. Novoderezhkina, et al.
Published: (2022-10-01)

Real-Time Autonomous Driving: A Unified Single-Stage Multi-Task Network Architecture
by: S. Raghavendra, et al.
Published: (2025-01-01)

Real-world outdoor air exposure effects in a model of the human airway epithelium – A comparison of healthy and asthmatic individuals using a mobile laboratory setting
by: Pavel Rossner, et al.
Published: (2025-01-01)

Comparison of pharmacokinetic similarity, immunogenicity, and safety of mepolizumab and BAT2606 in healthy Chinese men in a double-blinded, randomized, single-dose, three-arm parallel-group phase I trial
by: Cuiyun Li, et al.
Published: (2025-07-01)

A lightweight real-time unified detection model for rice and wheat ears in complex agricultural environments
by: Xiaojun Shen, et al.
Published: (2025-08-01)

Unifying human infectious disease models and real-time awareness of population- and subpopulation-level intervention effectiveness
by: Rachel L. Seibel, et al.
Published: (2025-06-01)